Health

  • September 23, 2026

    Patients Drop Fertility Fraud Suits Against Yale Medical School

    Five plaintiffs have dropped two related court actions against Yale School of Medicine, Yale New Haven Hospital and the estate of a Connecticut doctor accused of fraudulently using his own sperm to inseminate fertility patients, state court records show.

  • September 23, 2026

    Vein Tech Maker Escapes Suit Over DOJ Kickback Probe

    A New York federal judge has tossed, for now, a proposed investor class action alleging that vein disease device maker Inari Medical Inc.'s share price fell after it disclosed an investigation into its compliance with federal anti-kickback laws, finding the suit does not plausibly show Inari was paying healthcare providers unlawful kickbacks, among other things.

  • September 23, 2026

    Motley Rice Partner Tapped For Opioid Case Co-Lead Counsel

    The Ohio federal judge overseeing multidistrict opioid litigation appointed on Wednesday Donald Migliori, a managing partner at Motley Rice LLC, as co-lead counsel in the wake of the death of the firm's co-founder Joe Rice, who had served in the position for the past eight years.

  • September 23, 2026

    Healthcare Co. Trims But Can't Escape Retirement Plan Suit

    Nonprofit healthcare system Virtua Health can't avoid a proposed class action alleging its 401(k) plan unlawfully offered a risky and underperforming investment option that provided excessive compensation to plan service providers, a New Jersey federal judge ruled.

  • September 23, 2026

    NJ Bias Case Judge Won't Nix Hospital's NDA Rule Yet

    A New Jersey state judge said it was too early to strike down a hospital's nondisclosure agreement provision for internal investigations in a former director's suit alleging she was the target of a retaliatory investigation.

  • September 23, 2026

    Vividion Investor Wants IP Suit Over $2B Bayer Deal Revived

    CHP III LP urged the Delaware Supreme Court on Wednesday to revive its suit over allegedly diverted intellectual property in Vividion Therapeutics Inc.'s $2 billion sale to Bayer Corp., while the defendants argued the investor is trying to turn a corporate injury into a direct stockholder claim that did not survive the merger.

  • September 23, 2026

    Fla. Woman Gets $7.6M In Leg Amputation Med Mal Suit

    A Florida jury has awarded a woman $7.6 million after finding that her doctors were negligent and failed to recognize a medical emergency threatening her leg, resulting in its amputation.

  • September 23, 2026

    'Hanging In There' Doesn't Ax Disability Claim, 9th Circ. Says

    "Hanging in there" and working through the pain of a worsening disability is not a reason to reject the testimony of someone seeking Social Security benefits, the Ninth Circuit ruled Wednesday.

  • September 23, 2026

    NM County Faces Sanctions Over Protected Disclosures

    A New Mexico federal judge said a county violated a protective order by disclosing information from confidential documents in a state court malpractice suit, saying the county's defense of "we own the documents and we can do what we want with them" did not defeat the order's restriction on the materials.

  • September 23, 2026

    Nursing Facility Operator To Pay $1M In FCA Settlement

    The operators of a group of skilled nursing facilities in Massachusetts will pay $1 million to settle allegations that they overbilled Medicare and Medicaid by inflating the level of care patients needed, federal and state prosecutors announced Wednesday.

  • September 23, 2026

    Medicare Brokers Say Feds Won't Identify Alleged False Claims

    A group of insurance companies and brokers accused in a False Claims Act case of colluding to steer Medicare recipients to certain Medicare Advantage plans said Tuesday that the federal government has refused to provide specifics of the allegations.

  • September 23, 2026

    Nixon Peabody Adds Ex-State Counsel To SF Office

    A former chief counsel for California's Department of Aging has moved his healthcare practice to Nixon Peabody's San Francisco office after more than two years with Epstein Becker & Green PC.

  • September 23, 2026

    Genesis Healthcare Reports Last-Minute Facility Sale Snags

    Genesis Healthcare and the winning bidder for its 175 nursing homes told a Texas bankruptcy judge Wednesday they have fallen into a disagreement over $100 million of the $1 billion purchase price with the deadline to close the sale a week away.

  • September 23, 2026

    DOJ Pressed On Gender Care Ban In Federal HIV Program

    A Massachusetts federal judge on Wednesday skeptically questioned the Trump administration's authority to prohibit doctors from providing gender-affirming care as part of a longstanding, federally funded HIV program.

  • September 22, 2026

    Meta Flaunts 'Abuse' Of Atty-Client Privilege, Judge Told

    A California federal judge ordered Meta on Tuesday to rereview privilege designations on 300 documents in social media addiction litigation, after plaintiffs' lawyers cited a "culture of privilege abuse" epitomized by Instagram swag hats embroidered with "a/c priv" — the shorthand used to log withheld documents.

  • September 22, 2026

    UMass Hospital Co. Beats Ex-VP's COVID Vaccine Firing Claim

    A jury cleared a central Massachusetts hospital system of liability for terminating a compliance officer who refused a COVID-19 shot, finding Tuesday she failed to show a sincere religious belief against vaccination.

  • September 22, 2026

    CVS Beats Malpractice Suit Over Pharmacy Mix-Up

    A California appeals court on Tuesday upheld the dismissal of a suit accusing a CVS pharmacy of negligently giving the wrong prescription medication to a woman, which allegedly caused years of seizures, citing flawed expert testimony from plaintiff's expert.

  • September 22, 2026

    FDA Must Revisit MiMedx Wound Care Powder Classification

    A Georgia federal judge vacated the Food and Drug Administration's classification of biomedical company MiMedx's wound care treatment as a biological product, which carries heightened regulatory requirements, finding the agency's determination was arbitrary because it had classified similar products as devices.

  • September 22, 2026

    Colo. Hospital Seeks To Toss Meta Pixel Patient Data Suit

    A Colorado hospital system has asked a federal court to toss a proposed class action accusing it of illegally sharing patients' browsing data with Meta through a website tracking tool, arguing the patient who sued failed to show he was harmed and that the conduct does not violate federal wiretapping law.

  • September 22, 2026

    Healthcare PE Firm Sues Real Estate PE Firm Over 'Ironleaf' TM

    Healthcare technology-focused private equity firm Ironleaf Capital LP is accusing real estate private equity firm Ironleaf Equity Partners LLC in Washington federal court of infringing its "Ironleaf" and "Ironleaf Capital" trademarks by being a similarly named private equity firm.

  • September 22, 2026

    Healthcare AI Biz Valued At $900M After $100M Series C Round

    Healthcare-focused artificial intelligence company Heidi on Tuesday revealed that it has reached a $900 million valuation after raising $100 million in its latest funding round.

  • September 22, 2026

    Wash. Appeals Court Revives Colo. Tax Payment Dispute

    Whether intercompany payments count as profit, royalties or taxable management fees is a disputed question of fact, a Washington state appellate panel said Tuesday, ordering back to a trial court a dispute over whether a Colorado company and its affiliates owe Washington's business and occupation tax.

  • September 22, 2026

    Morrison Foerster Adds Former DOJ Official To Roster

    Morrison Foerster LLP is getting a new investigation and white collar defense partner fresh from the U.S. Department of Justice, where the attorney has spent more than a decade honing his legal chops, the firm has announced.

  • September 22, 2026

    Inspired Healthcare Seeks OK For $713M Asset Sale

    Inspired Healthcare on Tuesday asked a Texas bankruptcy judge to approve the sale of 30 of its senior living communities but to leave for later the question of how the $713 million in proceeds will be split among its creditors.

  • September 22, 2026

    RI Judge Vacates Feds' Noncitizen Benefit Restrictions

    New York and other states applauded a Rhode Island federal judge's finding that the Trump administration flouted rulemaking requirements when it reinterpreted a 30-year-old welfare reform bill to try to subject a slew of federally funded benefit programs to immigration status verification requirements.

Expert Analysis

  • Opinion

    Rule Of Law Requires Gov't Engagement With Bar, Not Retreat

    Author Photo

    A federal agency's absence from national and local bar conferences, most recently illustrated by the U.S. Department of Justice's withdrawal from a New York City Bar Association white collar conference, disserves the bar, the government lawyers themselves and, ultimately, the administration of justice, says Muhammad Faridi at Linklaters.

  • AG Watch: Oregon's Strategic Civil Enforcement Approach

    Author Photo

    Oregon Attorney General Dan Rayfield’s recent antitrust litigation activity and proposed staffing increase are the latest in a series of structural and policy changes that signal that the state Department of Justice is taking a more aggressive approach to civil enforcement, says Keturah Taylor at Cozen O'Connor.

  • Fed. Circ. Clarifies Standard For Contesting CICA Overrides

    Author Photo

    The Federal Circuit's recent holding in Life Science Logistics strengthens the hand of protesters facing an override of the Competition in Contracting Act stay, and a Court of Federal Claims decision the same day demonstrates that how a protester frames its requested relief remains critically important, says Richard Arnholt at Bass Berry.

  • The Paradoxical Duty To Adopt AI When You Can't Bill For It

    Author Photo

    Both billing for hours saved using artificial intelligence and preserving billable time by not adopting AI may violate rules of professional conduct, but until bar associations' ethics rules catch up to this emerging economic dilemma, firms must decide how to adjust fee structures themselves, says Ines Lassalle at Peyrot & Associates.

  • A Decade Later, Escobar Is Still Shaping FCA Cases

    Author Photo

    The U.S. Supreme Court's decision 10 years ago in Universal Health Services v. U.S. ex rel. Escobar changed the way in which lower courts evaluate False Claims Act cases — and the ruling remains vital in nearly every FCA case filed today, say attorneys at Bradley Arant.

  • How Hantavirus May Expand Cruise Ship Liability Concerns

    Author Photo

    In an incident like the recent hantavirus outbreak aboard a cruise ship, application of maritime negligence principles may expand beyond environmental exposure considerations to encompass how operators identify, respond to and manage emerging infectious disease risks in real time, says Eric Shane at Leesfield & Partners.

  • Ch. 15 Ruling Is A Restructuring Blueprint For Cannabis Cos.

    Author Photo

    The recent Cannabist Chapter 15 recognition order is arguably the most significant cannabis bankruptcy development in U.S. history, providing a concrete and tested road map by which such companies with foreign parent structures can access the protective machinery of U.S. bankruptcy law, say attorneys at Saul Ewing.

  • How FCA, FCPA Risks Are Shifting As Feds Pull Back

    Author Photo

    As the federal government continues its retreat from white collar enforcement, companies should expect False Claims Act risk to grow through private whistleblower suits and Foreign Corrupt Practices Act scrutiny to shift toward foreign prosecutors, requiring more adaptability as accountability becomes less centralized, says Temidayo Aganga-Williams at Selendy Gay.

  • Trump Admin's Agency Records Purge Tests Judicial Notice

    Author Photo

    While courts commonly take judicial notice of data in government websites and reports, the Trump administration's recent modification or wholesale deletion of these sources means that litigants must look elsewhere to support trial admission of this information, says Jon Gryskiewicz at Lewis Baach.

  • Series

    Cow Horse Makes Me A Better Lawyer

    Author Photo

    Moving an unwilling 800-pound cow while riding a horse at high speed is exhilarating, a little unhinged and, at least for me, a surprisingly effective training ground for litigation — both demand focus, preparation over rigid planning and the willingness to act despite fear, says Ashley Zitrin at Glenn Agre.

  • PowerSchool Data Breach Ruling Underscores PE Liability

    Author Photo

    The recent California federal court decision in PowerSchool, where Bain Capital was unable to dismiss claims relating to a data breach based in part on Bain's preinvestment activities, is an important addition to the line of cases addressing investor liability for acts of a portfolio company, says Mark Kelley at MoloLamken.

  • What Prop 65 Listings For Welding Fumes, Drugs Mean For Cos.

    Author Photo

    With California poised to add welding chemicals and three medications to its list of known carcinogens under Proposition 65, businesses must assess risks from nontraditional pharmaceutical dispensing, occupational and environmental exposures to welding operations, and downstream exposures from the manufacture of both types of substances, says Gregory Berlin at Alston & Bird.

  • West Coast Health Cos. Must Brace For Federal Enforcement

    Author Photo

    In light of the U.S. Department of Justice's newly established West Coast strike force targeting healthcare fraud across Northern California, Arizona and Nevada, health organizations will need to prioritize knowledge, vigilance and operational discipline to reduce exposure from potentially parallel criminal and civil investigations, says Michael Beckwith at Dickinson Wright.

  • High Court's Hikma Decision Reshapes 'Skinny Label' Suits

    Author Photo

    The U.S. Supreme Court's decision in Hikma v. Amarin marks a significant victory for generic drug manufacturers, but rather than putting an end to so-called skinny label inducement claims, it narrows and refocuses them, say attorneys at Sterne Kessler.

  • Checking For AI Errors Is Now A Two-Way Street

    Author Photo

    A handful of recent federal and state cases demonstrate the importance of checking for errors generated by artificial intelligence not only in your own court submissions, but also your opponent's, as well as when catching opposing counsel's AI mistakes could result in an award for attorney fees, says Tamara Barago at Hollingsworth.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.